Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02420717
Title Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center

B-cell acute lymphoblastic leukemia



Cyclophosphamide + Dexamethasone + Doxorubicin + Vincristine Sulfate


Mercaptopurine + Methotrexate + Prednisone + Vincristine Sulfate

Cytarabine + Leucovorin + Methotrexate

Age Groups: child | adult
Covered Countries USA

Facility Status City State Zip Country Details
M D Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field